Alison D. Schecter - 08 Feb 2022 Form 4 Insider Report for Axcella Health Inc.

Role
President - Research & Dev.
Signature
/s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
08 Feb 2022
Net transactions value
$0
Form type
4
Filing time
10 Feb 2022, 17:07:03 UTC
Previous filing
14 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +56,000 $0.000000 56,000 08 Feb 2022 Common Stock 56,000 $1.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.